174 related articles for article (PubMed ID: 35674307)
1. Roles of lncRNA-MALAT1 in the Progression and Prognosis of Gliomas.
Ji YL; Kang K; Lv QL; Wang DP
Mini Rev Med Chem; 2024; 24(8):786-792. PubMed ID: 37859309
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance.
Jegathesan Y; Stephen PP; Sati ISEE; Narayanan P; Monif M; Kamarudin MNA
Biomed Pharmacother; 2024 Mar; 172():116277. PubMed ID: 38377734
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives.
Liu J; Yang F; Hu J; Zhang X
CNS Neurosci Ther; 2024 May; 30(5):e14715. PubMed ID: 38708806
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin in cancer therapy: molecular mechanisms of action.
Dasari S; Tchounwou PB
Eur J Pharmacol; 2014 Oct; 740():364-78. PubMed ID: 25058905
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond.
Krichevsky AM; Uhlmann EJ
Neurotherapeutics; 2019 Apr; 16(2):319-347. PubMed ID: 30644073
[TBL] [Abstract][Full Text] [Related]
6. Autophagy in brain tumors: a new target for therapeutic intervention.
Kaza N; Kohli L; Roth KA
Brain Pathol; 2012 Jan; 22(1):89-98. PubMed ID: 22150924
[TBL] [Abstract][Full Text] [Related]
7. Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer.
Tanabe S; Boonstra E; Hong T; Quader S; Ono R; Cabral H; Aoyagi K; Yokozaki H; Perkins EJ; Sasaki H
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003016
[TBL] [Abstract][Full Text] [Related]
8. Clinical Targeting of Altered Metabolism in High-Grade Glioma.
Scott AJ; Lyssiotis CA; Wahl DR
Cancer J; 2021 Sep-Oct 01; 27(5):386-394. PubMed ID: 34570453
[TBL] [Abstract][Full Text] [Related]
9. DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.
Stornetta A; Zimmermann M; Cimino GD; Henderson PT; Sturla SJ
Chem Res Toxicol; 2017 Jan; 30(1):388-409. PubMed ID: 27936622
[TBL] [Abstract][Full Text] [Related]
10. Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma.
Kobayashi A; Kitagawa Y; Nasser A; Wakimoto H; Yamada K; Tanaka S
Cells; 2024 Mar; 13(5):. PubMed ID: 38474421
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between the Molecular Phenotypes of Brain Gliomas and the Imaging Features and Sensitivity of Radiotherapy and Chemotherapy.
Huang YR; Fan HQ; Kuang YY; Wang P; Lu S
Clin Oncol (R Coll Radiol); 2024 May; ():. PubMed ID: 38821723
[TBL] [Abstract][Full Text] [Related]
12. Alkylating anticancer agents and their relations to microRNAs.
Biersack B
Cancer Drug Resist; 2019; 2(1):1-17. PubMed ID: 35582140
[TBL] [Abstract][Full Text] [Related]
13. Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma.
Mellinghoff IK; Cloughesy TF
J Clin Oncol; 2022 Oct; 40(30):3510-3519. PubMed ID: 35201903
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment.
Agalakova NI
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256019
[TBL] [Abstract][Full Text] [Related]
15. Roles of exosome-derived non-coding RNA in tumor micro-environment and its clinical application.
Dou Q; Wang J; Yang Y; Zhuo W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):429-438. PubMed ID: 37643977
[TBL] [Abstract][Full Text] [Related]
16. Association of variations in the
Liu JS; Liu JY; Xiao Q; Li XP; Chen J; Liu ZQ
Front Pharmacol; 2023; 14():1119837. PubMed ID: 36969849
[No Abstract] [Full Text] [Related]
17. Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy.
Usman M; Beilerli A; Sufianov A; Kudryashov V; Ilyasova T; Balaev P; Danilov A; Lu H; Gareev I
Front Physiol; 2023; 14():1149821. PubMed ID: 36909247
[TBL] [Abstract][Full Text] [Related]
18. Precise Control of Glioma Cell Apoptosis Induced by Micro-Plasma-Activated Water (μ-PAW).
Zhang Y; Du X; Shi Q; Xiao W; Li H
Micromachines (Basel); 2022 Dec; 13(12):. PubMed ID: 36557443
[TBL] [Abstract][Full Text] [Related]
19. The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma.
Lu E; Gareev I; Yuan C; Liang Y; Sun J; Chen X; Beylerli O; Sufianov A; Zhao S; Yang G
Curr Pharm Des; 2022; 28(23):1863-1869. PubMed ID: 35674307
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
